Heyholder
‹ Back to the disclosure you were reading

GC Biopharma Corp. Single Sales/Supply Contract

GC Biopharma Corp.
View original on DART ↗0 votes · 0 comments

AI summary · Not investment advice

GC Biopharma signed a KRW 59.2 billion influenza vaccine supply contract with VaxThera Zona Franca S.A.S. for Colombia on 2026.10.30.

Contract amount

KRW 59.2 billion

Key facts

Contract details
Flu vaccine supply contractOther sales/supply contract
Recent revenue
KRW 2.0 trillionBased on 2025 consolidated financial statements
% of revenue
2.97%
Counterparty
VaxThera Zona Franca S.A.S.
Contract period
Oct 30, 2026 – Oct 30, 2036
Payment terms
No down payment or advance paymentNo down payment or advance payment
Contract date
Oct 30, 2026

Earlier Single Sales/Supply Contract filings from this company

Filings of the same type
FiledCounterpartyContract amount% of revenue
24.08.13BLAU Farmaceutica S.A.KRW 142.1 billion8.30%
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.